Biology and regulation of Il-13 receptor alpha 2

Il-13 受体 α2 的生物学和调控

• 批准号: 7095930
• 负责人: MICHAEL O DAINES
• 金额: $ 1.25万
• 依托单位: CINCINNATI CHILDRENS HOSP MED CTR
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-06-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7095930
• 关键词: asthma; biological signal transduction; clinical research; confocal scanning microscopy; cytokine receptors; gene mutation; human subject; interferon gamma; interleukin 10; interleukin 12; interleukin 13; interleukin 4; molecular pathology; protein localization; receptor binding; receptor expression; site directed mutagenesis; transfection; transforming growth factors; tumor necrosis factor alpha

DESCRIPTION (provided by applicant): Asthma is the most common indication for hospitalization and is the most common chronic disease of childhood. In animal models, IL-13 plays a key role in the development of asthma and allergic inflammation. We have demonstrated in our preliminary data that IL-13R alpha 2 is an intracellular molecule and its activation-dependent surface expression inhibits IL-13 signaling. This proposal describes a 5-year mentored training program for the development of an academic career in basic science research. The proposal will investigate surface expression regulation, subcellular localization, the mechanism of IL-13 signal suppression, and the related key structural motifs of IL-13R alpha 2. We will examine the role of a broad panel of regulatory cytokines in modulating its surface expression. Subcellular localization will be studied by confocal microscopy examining colocalization with known subcellular compartments. Transfection models will allow study of the effect of overexpression of this receptor. We have generated an in vitro model of IL-13 signaling that lacks competing endogenous IL-13 receptors. We will study IL-13 dependent signaling in these cells. We will generate cells expressing increasing amounts of IL-13R alpha 2 and determine if there is a dose-response of increasing expression of this molecule. This model will also be used to determine what structural elements are important to IL-13R alpha 2 modulating IL-13 signaling. IL-13R alpha 2 mutants will be created, truncating the protein to delete the cytoplasmic region, mutating the cytoplasmic tyrosine, or mutating the tri-leucine region that has been demonstrated to affect receptor internalization. We will study protein stability, IL-13 binding affinity, surface expression, and the effect on modulating IL-13 signaling in these mutants compared to wild type IL-13R alpha 2. This novel transfection model will determine the key structural elements in the IL-13R alpha 2 that allow inhibition of IL-13 signaling. This application represents the first extensive study of IL-13R alpha 2 cytokine dependent surface expression, its role in modulating IL-13 signaling, and the structural elements of IL-13R alpha 2 that are involved.

描述（由申请人提供）：哮喘是最常见的住院适应症，也是儿童最常见的慢性疾病。在动物模型中，IL-13在哮喘和过敏性炎症的发展中起关键作用。我们已经在我们的初步数据中证明了IL-13 R α 2是一种细胞内分子，其活化依赖性表面表达抑制IL-13信号传导。该提案描述了一个为期5年的指导培训计划，以发展基础科学研究的学术生涯。该提案将研究表面表达调控，亚细胞定位，IL-13信号抑制机制以及IL-13 R α 2的相关关键结构基序。我们将研究广泛的调控细胞因子在调节其表面表达中的作用。将通过共聚焦显微镜检查与已知亚细胞区室的共定位来研究亚细胞定位。转染模型将允许研究该受体过表达的影响。我们已经产生了IL-13信号转导的体外模型，其缺乏竞争性内源性IL-13受体。我们将研究这些细胞中的IL-13依赖性信号。我们将产生表达量增加的IL-13 R α 2的细胞，并确定该分子表达增加是否存在剂量反应。该模型还将用于确定哪些结构元件对IL-13 R α 2调节IL-13信号传导是重要的。将产生IL-13 R α 2突变体，截短蛋白质以删除胞质区域，突变胞质酪氨酸，或突变已被证明影响受体内化的三亮氨酸区域。我们将研究蛋白质稳定性、IL-13结合亲和力、表面表达，以及与野生型IL-13 R α 2相比，这些突变体对调节IL-13信号传导的影响。这种新的转染模型将确定IL-13 R α 2中允许抑制IL-13信号传导的关键结构元件。该申请代表了对IL-13 R α 2细胞因子依赖性表面表达、其在调节IL-13信号传导中的作用以及所涉及的IL-13 R α 2的结构元件的首次广泛研究。